BR9815384A - Composições de unguento em aerossol e método de fabricação - Google Patents
Composições de unguento em aerossol e método de fabricaçãoInfo
- Publication number
- BR9815384A BR9815384A BR9815384-6A BR9815384A BR9815384A BR 9815384 A BR9815384 A BR 9815384A BR 9815384 A BR9815384 A BR 9815384A BR 9815384 A BR9815384 A BR 9815384A
- Authority
- BR
- Brazil
- Prior art keywords
- ointment
- aerosol
- relief
- pain
- percent
- Prior art date
Links
- 239000002674 ointment Substances 0.000 title abstract 10
- 239000000443 aerosol Substances 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000001816 cooling Methods 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 3
- 239000003380 propellant Substances 0.000 abstract 3
- 230000001225 therapeutic effect Effects 0.000 abstract 3
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 206010042496 Sunburn Diseases 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000014617 hemorrhoid Diseases 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
''COMPOSIçõES DE UNGuENTO EM AEROSSOL E MéTODO DE FABRICAçãO'' São proporcionadas composições de ung³ento em aerossol que, quando um depósito é expelido a partir de um recipiente aerossol por sobre um tecido machucado, é aplicado ao referido tecido um ung³ento frio através do que se exerce um efeito refrescante que alivia a dor e um efeito terapêutico medicinal sobre os referidos tecidos. Exemplos de ung³entos típicos da invenção são aqueles para o alívio temporário das hemorróidas, tratamento de queimaduras provocadas pelo sol e alívio da dor artrítica. Um método para a fabricação das composições de ung³ento em aerossol capazes de expelir a partir de recipientes aerossol ung³entos que exerçam sobre os tecidos danificados tanto um efeito refrescante que alivia a dor além de um efeito terapêutico medicinal. As composições aerossol que melhoram a ação terapêutica de um ung³ento através da produção de um instantâneo efeito refrescante prolongado proporciona rápido alívio para a dor e coceira bem como uma tendência à retração de tecidos inflamados e intumescidos antecipadamente à ação mais lenta de qualquer medicamento presente no ung³ento, onde a composição aerossol consiste de a partir de cerca de 10 até cerca de 60 por cento em peso de um componente ung³ento e a partir de cerca de 40 até cerca de 90 porcento em peso de propelente liq³efeito que é um propelente predominantemente não polar, e onde a soma do componente ung³ento e propelente e igual a 100 por cento em peso da composição.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94753097A | 1997-10-02 | 1997-10-02 | |
| US7506798A | 1998-05-08 | 1998-05-08 | |
| PCT/US1998/020335 WO1999017739A1 (en) | 1997-10-02 | 1998-09-30 | Aerosol ointment compositions and method of manufacture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9815384A true BR9815384A (pt) | 2000-10-31 |
Family
ID=26756400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9815384-6A BR9815384A (pt) | 1997-10-02 | 1998-09-30 | Composições de unguento em aerossol e método de fabricação |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1019024B1 (pt) |
| AT (1) | ATE257372T1 (pt) |
| AU (1) | AU9588598A (pt) |
| BR (1) | BR9815384A (pt) |
| CA (1) | CA2306484A1 (pt) |
| DE (1) | DE69821010T2 (pt) |
| WO (1) | WO1999017739A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214318B1 (en) * | 1997-10-02 | 2001-04-10 | Oms Holdings Llc | Aerosol ointment compositions for topical use |
| US8263580B2 (en) | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
| EP2526930B1 (en) | 2005-06-01 | 2013-12-25 | GlaxoSmithKline Intellectual Property Development Limited | Vitamin formulation |
| WO2020223093A1 (en) | 2019-04-30 | 2020-11-05 | Bayer Healthcare Llc | Topical analgesic gel compositions |
| US12097186B2 (en) | 2019-04-30 | 2024-09-24 | Bayer Healthcare Llc | Topical analgesic compositions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1123868A (en) * | 1965-09-08 | 1968-08-14 | Philips Roxane | Compositions for treating anal and perianal disorders |
| US3947566A (en) * | 1970-08-03 | 1976-03-30 | Phoenix Research Inc. | Effervescent medicaments |
| ZA77943B (en) * | 1976-03-19 | 1977-12-28 | Upjohn Co | Topical steroid clindamycin preparations |
| GB1539450A (en) * | 1976-06-08 | 1979-01-31 | Wyeth John & Brother Ltd | Thiazole derivatives |
| DE3810730A1 (de) * | 1988-03-30 | 1989-10-12 | Desitin Arzneimittel Gmbh | Spruehbare salbenzusammensetzung |
| WO1992011839A1 (en) * | 1991-01-08 | 1992-07-23 | Leonard Mackles | Anhydrous aerosol |
| CA2110176A1 (en) * | 1992-03-28 | 1993-10-14 | Akira Yanagawa | Topical preparation for healing wounds of the skin |
| US5618515A (en) * | 1992-08-19 | 1997-04-08 | Blistex Inc. | Aerosol spray composition for the treatment of dermal burns by cooling and anesthetizing the wound and valved container for dispensing same |
| CA2232677A1 (en) * | 1995-09-22 | 1997-03-27 | Phylomed Corporation | Topical formulations and delivery systems |
-
1998
- 1998-09-30 WO PCT/US1998/020335 patent/WO1999017739A1/en not_active Ceased
- 1998-09-30 CA CA002306484A patent/CA2306484A1/en not_active Abandoned
- 1998-09-30 DE DE69821010T patent/DE69821010T2/de not_active Expired - Fee Related
- 1998-09-30 BR BR9815384-6A patent/BR9815384A/pt not_active IP Right Cessation
- 1998-09-30 EP EP98949592A patent/EP1019024B1/en not_active Expired - Lifetime
- 1998-09-30 AU AU95885/98A patent/AU9588598A/en not_active Abandoned
- 1998-09-30 AT AT98949592T patent/ATE257372T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2306484A1 (en) | 1999-04-15 |
| WO1999017739A1 (en) | 1999-04-15 |
| DE69821010D1 (de) | 2004-02-12 |
| EP1019024A1 (en) | 2000-07-19 |
| ATE257372T1 (de) | 2004-01-15 |
| EP1019024B1 (en) | 2004-01-07 |
| WO1999017739B1 (en) | 1999-05-27 |
| AU9588598A (en) | 1999-04-27 |
| DE69821010T2 (de) | 2004-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2219115A1 (en) | N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs | |
| BR9914617A (pt) | Composições de unguento em aerossol e método de fabricação | |
| WO2003004000A3 (en) | Topical composition for treating pain | |
| EP1419803A3 (en) | Pharmaceutical composition for topical administration comprising an antiviral substance and a glucocorticoid | |
| AU2745700A (en) | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same | |
| WO2002102394A3 (en) | Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport | |
| WO1999001103A3 (en) | Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition | |
| WO2002096435A3 (en) | Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol | |
| WO2003018619A3 (en) | Antimicrobial and anti-inflammatory peptides | |
| WO2000027381A3 (en) | Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions | |
| WO2005007072A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
| AU2732597A (en) | Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs | |
| CA2198706A1 (en) | Methods for the treatment of inflammatory joint disease | |
| WO2002009639A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
| EP1157698A3 (en) | Treatment of inflammatory diseases with oxypurine nucleosides | |
| WO2001051044A3 (en) | Substances for use in treating psoriasis | |
| AU2002227052A1 (en) | Treatments for neurogenetic disorders, impulse control disorders, and wound healing | |
| BR9815384A (pt) | Composições de unguento em aerossol e método de fabricação | |
| EP2138175A3 (en) | Formulations comprising valsartan for treating diabetes or microalbuminuria | |
| AU8020698A (en) | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain | |
| WO1999061010A3 (en) | Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound | |
| WO2003057172A3 (en) | Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses | |
| ZA979647B (en) | Heterocyclic compounds, compositions and uses. | |
| CA2404210A1 (en) | Pharmaceutical gel composition | |
| ZA979650B (en) | Heterocyclic compounds, compositions and uses. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1942 DE 25 - 03 -2008. |